Link Securities | The Board of Directors of Faes Farma (FAE) has approved the payment of a cash dividend on account of the 2025 results of €0.041 gross per share. The cash dividend will be paid in January 2026 and will amount to approximately €12.8 million. The relevant dates for this operation are as follows: Last trading date for shares with dividend rights: 7 January. Date from which shares will…
CdM | Faes Farma (FAES) profits have suffered in the first nine months of 2025. According to the company’s report to the Spanish National Securities Market Commission (CNMV), net profits between January and September amounted to €73.56 million, 7.9% less than the €79.84 million recorded in the same period in 2024. EBITDA stood at £106.5 million until September, down 2.7%. However, this figure was at the high end of the…
Link Securities | In an interview with the newspaper Expansión, the CEO of Faes Farma (FAE), Eduardo Recoder, indicated that the acquisitions of Italy’s Sifi and Portugal’s Edol are strategic and transformational. Faes Farma will now pause its inorganic growth to integrate the two companies, although it will remain open to exploring opportunities. These two companies will contribute €130 million to Faes’ business, which had a turnover of €510 million…
Link Securities | At the Extraordinary General Shareholders’ Meeting of Faes Farma (FAE) held on Wednesday, the proposal of the Board of Directors contained in the sole item on the Agenda was approved: Approval of the acquisition of 100% of the share capital of Sifi, S.P.A. With this approval by the shareholders, Faes Farma takes another step towards completing the acquisition of Sifi, which represents a transformational step in its…
Renta 4: Since 2020, the stock has accumulated four years of consolidation since 2012. These consolidation ranges are usually of continuity of the previous trend (upwards since 2012). Since March, the price has shown a striking robustness and faces the passage of the guideline linking the highs of 2007, with those of 2020 and 2022 at €3.70, above which it would confirm its good form. The narrowness of the price…
Norbolsa | Faes Farma (FAES) held its shareholders’ meeting on Tuesday, where it endorsed the appointment of the new CEO Eduardo Recoder de la Cuadra, who will take up his new position on 1 September. On the other hand, the company reported that it is studying the purchase of a European pharmaceutical company, without giving additional data. As for the new Derio plant, they recalled that it will come into…
Renta 4 | Faes Farma will expand its industrial capacity with a new production plant in Derio (Vizcaya) in order to meet the strong growth expected by the company beyond 2024. The estimated investment will be around €150 M. This will be implemented over the next 4 years and will require an increase in staff of about 200 workers. The new plant will be located in the Zamudio Technology Park, with the potential to manufacture more than 100 M units of medicines.